Facebook
Instagram
Linkedin
Pinterest
Twitter
Youtube
Home
Safe Snack Guide
Peanut and Tree Nut Free Edition
Milk Free Edition
Sesame Free Edition
Gluten Free Edition
Custom Edition
Allergence
Coupons
About Us
Media Kit
Advertising Guide
Manufacturer Partnership
Subscribe to our newsletter
Contact Us
Resources
FAQ
Tools for Schools
Coupons
Search
Home
Safe Snack Guide
Peanut and Tree Nut Free Edition
Milk Free Edition
Sesame Free Edition
Gluten Free Edition
Custom Edition
Allergence
Coupons
About Us
Media Kit
Advertising Guide
Manufacturer Partnership
Subscribe to our newsletter
Contact Us
Resources
FAQ
Tools for Schools
Coupons
Search
Tag: efficacy
Most Adults Achieve Food Allergy Desensitization with Oral Immunotherapy
Dave Bloom
-
2022/11/04
But rates were lower than those for children and adolescents.
FDA Has Questions About Viaskin Peanut Efficacy, Delays Meeting with DBV...
Dave Bloom
-
2020/03/17
The company warned the FDA's target date for their decision on approval could be delayed.
European Phase 3 Trial of AR101 Peanut OIT Candidate Meets Primary...
News Wire ~ 3rd Party Press Release
-
2019/03/25
Company Intends to Submit European MAA in Mid-2019.
Results of Phase III Trial of Aimmune's Peanut OIT Therapy
Dave Bloom
-
2018/02/20
After one year, 3/4 of patients ages 4-17 who received the therapy were able to consume a minimum of 300mg of peanut. Results for adults were less clear.
Viaskin Peanut Phase III Trial Falls Short, Still Chance for FDA...
Dave Bloom
-
2017/10/24
The Viaskin Peanut patch therapy still has 50:50 chance of approval according to research note.